166977-43-1

166977-43-1 structure

Name: BMS 453
Chemical Name: 4-[(E)-2-(5,5-Dimethyl-8-phenyl-5,6-dihydro-2-naphthalenyl)vinyl] benzoic acid
CAS Number: 166977-43-1
Molecular Formula: C₂₇H₂₄O₂
Molecular Weight: 380.47800
Catalog: Signaling Pathways Metabolic Enzyme/Protease RAR/RXR
Create Date: 2016-12-28 17:32:02
Modify Date: 2025-09-11 11:01:32
BMS453 (BMS-189453), a synthetic retinoid, is a RARβ agonist and a RARα/RARγ antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ[1][2].

Name	4-[(E)-2-(5,5-Dimethyl-8-phenyl-5,6-dihydro-2-naphthalenyl)vinyl] benzoic acid
Synonyms	BMS-189453

Description	BMS453 (BMS-189453), a synthetic retinoid, is a RARβ agonist and a RARα/RARγ antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Metabolic Enzyme/Protease >> RAR/RXR
In Vitro	BMS453 (1 μM; 11 hours; 184 and HMEC cells) treatment inhibits the proliferation of normal breast cell growth without significantly inducing apoptosis[2]. BMS453 (1 μM; 5 days; 184 and HMEC cells) treatment inhibits normal breast cell proliferation by causing G1 arrest[2]. BMS453 (1 μM; 24-72 hours; 184 cells) treatment induces Rb hypophosphorylation and decrease CDK2 kinase activity. BMS453 increases total p21 protein levels and CDK2-bound p21 protein, but does not change CDK4-bound p21[2]. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ[2]. Cell Proliferation Assay[2] Cell Line: Normal human mammary epithelial cells (184 and HMEC) Concentration: 1 μM Incubation Time: 11 hours Result: Inhibited 3H-thymidine uptake in normal breast cells (184 and HMEC) by 40 %. Cell Cycle Analysis[2] Cell Line: Normal human mammary epithelial cells (184 and HMEC) Concentration: 1 μM Incubation Time: 5 days Result: Increased the proportion of cells in G0/G1 phase and decreased the proportion of cells in S phase. Western Blot Analysis[2] Cell Line: 184 cells Concentration: 1 μM Incubation Time: 24 hours, 48 hours, 72 hours Result: Induced Rb hypophosphorylation and decrease CDK2 kinase activity.
References	[1]. J Y Chen, et al. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 1995 Mar 15;14(6):1187-97. [2]. L Yang, et al. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest. Oncogene. 2001 Nov 29;20(55):8025-35.

Molecular Formula	C₂₇H₂₄O₂
Molecular Weight	380.47800
Exact Mass	380.17800
PSA	37.30000
LogP	6.66820

RIDADR	NONH for all modes of transport

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

166977-43-1	1549811-36-0
1675201-90-7	543730-41-2
1781932-33-9	1174046-72-0
918348-67-1	253174-92-4
1319719-58-8	1059734-66-5
511552-45-7	1060817-33-5
104615-73-8	1049564-26-2
287121-33-9	202136-44-5
903131-52-2	186550-85-6
259750-56-6	203071-49-2